Top-Three CRO Signs Master Services Agreement with NewCardio
Santa Clara, CA-August 27, 2009
NewCardio, Inc., a cardiac diagnostic and services company, announced that a top-three contract research organization has signed a Master Services Agreement (MSA) to use the company's QTinno software suite as its technology in fully automated Thorough QT (TQT) and Phase 1 studies delivered by its centralized ECG core lab.
NewCardio expects to collaborate on the first fully automated study, tentatively scheduled to begin during the third quarter of 2009.
NewCardio’s innovative 3D ECG platform technology is intended to improve the accuracy and increase the diagnostic value of the standard 12-lead electrocardiogram (ECG). QTinno is a software suite that provides an automated analysis of QT intervals and other ECG-based cardiac safety for the pharmaceutical industry and drug regulators.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
